Animal Antibiotics and Antimicrobials Market Size | Share | Global Forecast 2023

The global animal antibiotics and antimicrobials market size was valued at USD 4,561.3 million in 2021 and is poised to grow at a significant CAGR of 4.2% during the forecast period 2023-29. The Animal Antibiotics and Antimicrobials Market refers to the market for veterinary drugs used to prevent and treat bacterial infections in animals. Antibiotics and antimicrobials are used to treat a wide range of bacterial infections in animals, including respiratory, gastrointestinal, and urinary tract infections. They are also used as a preventive measure to control the spread of bacterial infections in animal populations. The Animal Antibiotics and Antimicrobials Market includes a wide range of products, such as penicillins, tetracyclines, macrolides, aminoglycosides, and fluoroquinolones. The market is driven by the increasing demand for animal protein, the need to improve animal health and welfare, and the growing incidence of bacterial infections in animals.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/animal-antibiotics-and-antimicrobials-market/

Animal Antibiotics and Antimicrobials Market Growth Factors:

The Animal Antibiotics and Antimicrobials Market is expected to experience growth due to the following dynamics:

Increasing demand for animal protein: The growing global population and changing dietary patterns have led to increasing demand for animal protein, which in turn has led to an increase in the number of livestock and poultry farms. This has created a demand for animal antibiotics and antimicrobials to treat and prevent bacterial infections in animals.

Technological advancements: The development of new antibiotics and antimicrobials that are more effective and have fewer side effects is driving the growth of the market. Advancements in drug delivery technologies are also leading to the development of new and innovative antibiotic products.

Animal health and welfare concerns: The increasing focus on animal health and welfare is driving the demand for antibiotics and antimicrobials. The use of these products can help to prevent and treat bacterial infections, which can improve the overall health and welfare of animals.

Growing prevalence of bacterial infections: The incidence of bacterial infections in animals is increasing, which is driving the demand for antibiotics and antimicrobials. Bacterial infections can be costly for farmers and can have significant impacts on animal health and welfare.

The global animal antibiotics and antimicrobials market segmentation:
1) By Product Type: Tetracyclines, Penicillins, Sulfonamides, Macrolides, Aminoglycosides, Lincosamides, Fluoroquinolones, Cephalosporins and Other Antimicrobials and Antibiotics
2) By Mode of Delivery: Premixes, Oral Powder, Oral Solution, Injection and Others
3) By Animal Type: Food-Producing Animals, Companion Animals

Animal Antibiotics and Antimicrobials Market Regional Analysis:
The Animal Antibiotics and Antimicrobials Market is analyzed on a regional basis to identify trends and growth opportunities across different geographies.

North America: The North American region is expected to hold a significant share in the Animal Antibiotics and Antimicrobials Market. The increasing demand for animal protein, the growing prevalence of bacterial infections, and the presence of a large number of animal healthcare companies in the region are driving the growth of the market.

Asia Pacific: The Asia Pacific region is expected to witness significant growth in the Animal Antibiotics and Antimicrobials Market due to the increasing demand for animal protein, the growing prevalence of bacterial infections, and increasing investments by animal healthcare companies in the region.

Request sample report at https://precisionbusinessinsights.com/request-sample/?product_id=56106

Key players profiles in the Animal Antibiotics and Antimicrobials Market report are Boehringer Ingelheim (Germany), Zoetis Inc. (US), Elanco Animal Health (US), Merck & Co. Inc (US), Phibro, Animal Health (US), Virbac (France), Vetoquinol S.A. (France), Ceva Santé Animale (France), Dechra Pharmaceuticals Plc (UK), Kyoritsu Seiyaku (Japan)

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Website: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.